The 10% owner's open-market purchase is a modest bullish signal, but the small size relative to market cap limits its impact. Monitor for any subsequent filings (e.g., 8-K, press release) that might explain the insider's conviction, and watch for any additional insider buying or selling in the coming weeks to confirm the signal.
PRTA drugs
PRTA drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 10 $9.12entry
- T+1 · 3mo ago +1.10%α +1.42% · $9.22
- T+5 · 3mo ago −2.63%α −2.58% · $8.88
- T+20 · 2mo ago +4.61%α +5.52% · $9.54
- T+60 · 14d ago −9.43%α −7.53% · $8.26
Price Chart
How similar events traded
Executive Summary
William P. Scully, a 10% owner of Prothena, made a single-day open-market purchase of 37,500 shares for $323K on August 7, 2026, at $8.62 per share. This is a conviction buy from a major insider, representing 0.07% of the company's $459M market cap, which is a modest but notable signal given the insider's status and the lack of any recent insider selling at this level.
Key Financial Metrics
Key Facts
- 10% owner William P. Scully purchased 37,500 shares for $323,220 on August 7, 2026.
- The purchase was made at $8.62 per share, an open-market transaction.
- Total purchase value represents 0.07% of Prothena's $459M market cap.
- This is a single-insider conviction buy, not a cluster, but from a significant insider (10% owner).
Financial Impact
$323K insider purchase by 10% owner, representing 0.07% of market cap.
Risk Factors
- The purchase is small relative to market cap (0.07%), limiting its signaling power.
- The stock has a 67% bullish analyst consensus, which may already be priced in.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001045463-26-000010 |
Track record
20 reports on PRTA
7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +14.11% at T+60 after the Jun 12, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
- Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
- Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
- Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
- Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers